Monday, October 13, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle’s AI Ambitions Face Critical Test at Upcoming Conference

Felix Baarz by Felix Baarz
October 13, 2025
in AI & Quantum Computing, Analysis, Earnings, Tech & Software
0
Oracle Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Wall Street’s attention is firmly fixed on Oracle as the software giant approaches what market experts are calling its most significant corporate event in twenty years. The upcoming “Oracle AI World” conference in Las Vegas arrives as the company’s shares rebound from recent declines, with investors seeking clear evidence that Oracle’s artificial intelligence ventures can translate into sustainable profitability.

Unprecedented Analyst Expectations

Market sentiment remains decidedly bullish, with two prominent investment banks recently reinforcing their buy ratings for Oracle. Citi analyst Tyler Radke views the stock’s recent 11 percent pullback as an attractive entry point, projecting remarkable annual profit growth of 30 percent through 2030.

Even more optimistic is Evercore ISI’s Kirk Materne, who considers a $200 billion revenue target for Oracle’s cloud division by 2030 to be “entirely realistic.” This projection substantially exceeds the company’s previously communicated goal of $144 billion.

Record Backlog Fuels Investor Optimism

The source of market enthusiasm stems from Oracle’s staggering $450 billion contract backlog, secured through multi-billion dollar agreements with major AI enterprises. Soaring demand for AI infrastructure has already propelled the company’s shares upward by more than 50 percent since the beginning of the year.

Should investors sell immediately? Or is it worth buying Oracle?

However, this explosive growth presents its own challenges. Investors are increasingly questioning whether massive investments in new data center infrastructure will ultimately deliver satisfactory returns. The substantial capital requirements for expanding AI capabilities create uncertainty around future profit margins.

Pivotal October Event

All eyes now turn to the October 15-16 “Oracle AI World” conference, where Oracle leadership faces mounting pressure to address profitability concerns. Market participants eagerly anticipate Chairman Larry Ellison’s keynote address and detailed financial projections extending to 2030. TD Cowen has characterized the upcoming event as Oracle’s “most anticipated” analyst day in two decades.

The stakes couldn’t be higher. Oracle must not only present compelling long-term objectives but also articulate a definitive strategy for converting enormous AI demand into profitable operations. The company’s ability to convince investors of its path to monetization will likely determine whether recent stock performance represents sustainable momentum or temporary enthusiasm.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from October 13 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 13.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Applied Materials Stock
AI & Quantum Computing

Applied Materials Navigates Geopolitical Headwinds and AI Opportunities

October 13, 2025
Intuitive Surgical Stock
AI & Quantum Computing

Surgical Robotics Leader Intuitive Surgical Gains FDA Nod for AI-Powered Diagnostic Enhancement

October 13, 2025
Starbucks Stock
Analysis

Starbucks Shares Face Critical Holiday Test Amid Diverging Analyst Views

October 13, 2025
Next Post
Coinbase Stock

Coinbase Poised to Bridge Traditional Finance and Crypto with Native Token Launch

Salesforce Stock

Salesforce Bets Big on AI to Reignite Growth Momentum

BioNTech Stock

EU Commits €95 Million to BioNTech's African Manufacturing Initiative

Recommended

Hanesbrands Stock

Acquisition Battle Heats Up as Gildan Moves to Acquire Hanesbrands

2 months ago
Radio telecommunications

Gina Carano Files Lawsuit Against Disney and Lucasfilm Implications for the Entertainment Industry

2 years ago
RLI stock news

Unraveling the Enigma: Analyzing Ollie’s Bargain Outlet Holdings, Inc.’s Potential in an Intricate Market

2 years ago

Lexicon Pharmaceuticals to Resubmit NDA for Sotagliflozin as Complement to Insulin Treatment for Type 1 Diabetes

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Starbucks Shares Face Critical Holiday Test Amid Diverging Analyst Views

Clinical Trial Data Sparks Investor Interest in Assembly Biosciences

Meta’s AI Gambit Faces Critical Test as Earnings Loom

PepsiCo Stock Gets Boost from Strong Earnings and Leadership Shake-Up

TSMC Shares Face Geopolitical Test Amid AI Boom

Fiserv Shares Hit Critical Low as Stablecoin Initiative Raises Questions

Trending

Applied Materials Stock
AI & Quantum Computing

Applied Materials Navigates Geopolitical Headwinds and AI Opportunities

by Felix Baarz
October 13, 2025
0

The semiconductor equipment leader Applied Materials finds itself navigating a complex landscape, caught between significant revenue threats...

Intuitive Surgical Stock

Surgical Robotics Leader Intuitive Surgical Gains FDA Nod for AI-Powered Diagnostic Enhancement

October 13, 2025
AirbusV Stock

Asian Aviation Expansion Fuels Airbus’s Market Momentum

October 13, 2025
Starbucks Stock

Starbucks Shares Face Critical Holiday Test Amid Diverging Analyst Views

October 13, 2025
Assembly Biosciences Stock

Clinical Trial Data Sparks Investor Interest in Assembly Biosciences

October 13, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Applied Materials Navigates Geopolitical Headwinds and AI Opportunities
  • Surgical Robotics Leader Intuitive Surgical Gains FDA Nod for AI-Powered Diagnostic Enhancement
  • Asian Aviation Expansion Fuels Airbus’s Market Momentum

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com